Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD-Reference-Cited by-同舟云学术

Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD

Published:2023 Issue:8 Volume:2 Page:1093-1102
ISSN:2772-5723
Container-title:Gastro Hep Advances
language:en
Short-container-title:Gastro Hep Advances

Author:

Toyoda Hidenori^ORCID,Fujii Hideki,Iwaki Michihiro,Hayashi Hideki,Oeda Satoshi,Hyogo Hideyuki,Kawanaka Miwa,Morishita Asahiro,Munekage Kensuke,Kawata Kazuhito,Yamamura Sakura,Sawada Koji,Maeshiro Tatsuji,Tobita Hiroshi,Yoshida Yuichi,Naito Masafumi,Araki Asuka,Arakaki Shingo,Kawaguchi Takumi,Noritake Hidenao,Ono Masafumi,Masaki Tsutomu,Yasuda Satoshi,Tomita Eiichi,Yoneda Masato,Kawada Norifumi,Tokushige Akihiro,Kamada Yoshihiro,Takahashi Hirokazu,Ueda Shinichiro,Aishima Shinichi,Sumida Yoshio,Nakajima Atsushi,Okanoue Takeshi

Publisher

Elsevier BV

Reference32 articles.

1. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

3. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease;J Hepatol,2016

4. Long-term follow-up of patients with nonalcoholic fatty liver;Rafiq;Clin Gastroenterol Hepatol,2009

5. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention;Medicine in Novel Technology and Devices;2024-12

2. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

3. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD);Obesity Facts;2024